Ganga Pharmaceuticals IPO listing price is ₹ 14.50, issue price is [●], and currently trading at ₹ 14.80 as on May 22, 2025. Ganga Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Ganga Pharmaceuticals IPO is a Fixed Price listing on BSE SME exchange. The company is based in Mumbai and caters to Pharmaceutical - Ayurvedic sector. First Overseas Capital is the merchant banker of Ganga Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Ganga Pharmaceuticals IPO offer price is ₹ 15.00 and got listed at ₹ 14.50. Read Ganga Pharmaceuticals IPO details mentioned above.The IPO of Ganga Pharmaceuticals Limited was listed on 22nd February 2016. As of today, Ganga Pharmaceuticals IPO is trading at ₹ 14.80, compared to the previous day’s close of ₹ 13.51. Read the report above for detailed IPO performance.
The issue price of Ganga Pharmaceuticals IPO was [●] per equity share.
Ganga Pharmaceuticals IPO was listed at ₹14.50 on the stock exchange on 22nd February 2016. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 22, 2025, the current market price of Ganga Pharmaceuticals IPO is ₹ 14.80.
The 52-week high for Ganga Pharmaceuticals IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Ganga Pharmaceuticals IPO listed at ₹ 14.50 against the issue price of [●] per equity share, showing a listing day gain/loss of -0.5 (-3.33%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Ganga Pharmaceuticals IPO stock moved from its listing price of ₹ 14.50 to the current price of ₹14.80 per equity share, reflecting a change of 2.07% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Ganga Pharmaceuticals IPO issue date of May 22, 2025 and CMP of ₹14.80, the estimated CAGR is approximately -0.14%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Ganga Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Ganga Pharmaceuticals Financial Review Page
Merchant Banker(s) of Ganga Pharmaceuticals IPO: First Overseas Capital Limited
Ganga Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Ganga Pharmaceuticals IPO listed at a listing price of 14.50 against the offer price of 15.00.
The current market price of Ganga Pharmaceuticals is 14.80.
Why Us?